Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-3.76	103.80	107.85
Graham Fair Price	147.20	2.51	1.02
PEG	-97.84	0.08	-3.82
Price/Book	-20.06	1.23	1.54
Price/Cash Flow	81.75	-182.31	-998.97
Prices/Earnings	-86.71	42.20	317.59
Price/Sales	-24.22	5.01	6.61
Price/FCF	81.75	-182.31	-998.97
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	55.58	0.12	0.08
Operating Margin	-34.68	0.03	-0.04
ROA	516.40	< 0.005	< 0.005
ROE	< 0.005	< 0.005	501.61
ROIC	< 0.005	< 0.005	22.62
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.58	1.77	-67.49
Dividends QOQ	1.05	-0.44	-57.78
EBIT QOQ	-2.35	1.69	-28.02
EPS QOQ	-0.83	5.11	514.09
FCF QOQ	-1.05	-3.41	-226.31
Revenue QOQ	< 0.005	0.06	650.50
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	104.26	90.96	-12.76
Days Sales Outstanding (DSO)	151.30	143.10	-5.42
Inventory Turnover	0.86	0.99	14.62
Debt/Capitalization	0.28	0.14	-49.64
Quick Ratio	1.28	1.42	10.30
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	6.15	6.20	0.79
Cash	2.45	2.53	3.26
Capex	-0.16	-0.08	50.34
Free Cash Flow	< 0.005	-0.04	-341.49
Revenue	1.43	1.52	6.32
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.70	1.81	6.78
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	2.72	-21.08	674.52
Naive Interpretation	Member

06 - Financial Health · Weak

Rating